Literature DB >> 29860908

Cytoreductive Nephrectomy - Patient Selection Is Key.

Robert J Motzer1, Paul Russo1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29860908     DOI： 10.1056/NEJMe1806331

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Renal cell carcinoma: standards and controversies.

Authors:  Tobias Klatte; Grant D Stewart
Journal:  World J Urol       Date:  2018-12       Impact factor: 4.226

2.  External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Authors:  Lorenzo Marconi; Roderick de Bruijn; Erik van Werkhoven; Christian Beisland; Kate Fife; Axel Heidenreich; Anil Kapoor; Jose Karam; Caroline Kauffmann; Tobias Klatte; Boerje Ljungberg; Surena Matin; Daniel Sjoberg; Michael Staehler; Grant D Stewart; Simon Tanguay; Robert Uzzo; Sarah Welsh; Lori Wood; Chris Wood; Axel Bex
Journal:  World J Urol       Date:  2018-08-01       Impact factor: 4.226

Review 3.  Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma.

Authors:  Bryden Considine; Michael E Hurwitz
Journal:  Curr Oncol Rep       Date:  2019-03-08       Impact factor: 5.075

4.  Refractory Renal Cell Cancer with Gastro-renal Fistula: A Rare Complication.

Authors:  Eric Tam; Elvira Neculiseanu; Gurinder Sidhu
Journal:  Cureus       Date:  2020-01-06

5.  The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience.

Authors:  Andrew W Silagy; Roy Mano; Kyle A Blum; Renzo G DiNatale; Julian Marcon; Satish K Tickoo; Eduard Reznik; Jonathan A Coleman; Paul Russo; A Ari Hakimi
Journal:  Urology       Date:  2019-11-11       Impact factor: 2.649

6.  Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy.

Authors:  Francesco Massari; Vincenzo Di Nunno; Lidia Gatto; Matteo Santoni; Riccardo Schiavina; Laura Cosmai; Eugenio Brunocilla; Andrea Ardizzoni; Camillo Porta
Journal:  Target Oncol       Date:  2018-12       Impact factor: 4.493

7.  The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.

Authors:  Renzo G DiNatale; Wanling Xie; Maria F Becerra; Andrew W Silagy; Kyrollis Attalla; Alejandro Sanchez; Roy Mano; Julian Marcon; Kyle A Blum; Nicole E Benfante; Martin H Voss; Robert J Motzer; Jonathan Coleman; Toni K Choueiri; Ed Reznik; Paul Russo; Daniel Y C Heng; A Ari Hakimi
Journal:  Eur Urol Oncol       Date:  2019-11-14

Review 8.  The evolving role of cytoreductive nephrectomy: incorporating genomics of metastatic renal cell carcinoma into treatment decisions.

Authors:  Roy Mano; Nikhil Gopal; A Ari Hakimi
Journal:  Curr Opin Urol       Date:  2019-09       Impact factor: 2.309

9.  Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrest.

Authors:  Gregory J Nason; Khaled Ajib; Guan Hee Tan; Dixon T S Woon; George T Christakis; Robert K Nam
Journal:  Can Urol Assoc J       Date:  2021-04       Impact factor: 1.862

10.  Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Authors:  Jeffrey Graham; J Connor Wells; Frede Donskov; Jae Lyun Lee; Anna Fraccon; Felice Pasini; Camillo Porta; I Alex Bowman; Georg A Bjarnason; D Scott Ernst; Sun Young Rha; Benoit Beuselinck; Aaron Hansen; Scott A North; Christian K Kollmannsberger; Lori A Wood; Ulka N Vaishampayan; Sumanta K Pal; Toni K Choueiri; Daniel Y C Heng
Journal:  Eur Urol Oncol       Date:  2019-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.